Advanced glycation end product precursors impair epidermal growth factor receptor signaling

Diabetes

Volumn 51, Issue 5, 2002, Pages 1535-1542

  Portero Otin, Manuel ^a   Pamplona, Reinald ^a   Bellmunt, Maria Josep ^a   Ruiz, Maria Cristina ^a   Prat, Joan ^a   Salvayre, Robert ^b   Nègre Salvayre, Anne ^b  

^a UNIVERSITY OF LLEIDA   (Spain)

^b UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALDEHYDE; AMINE; AMINOGUANIDINE; CARBONYL DERIVATIVE; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYOXAL; LYSINE DERIVATIVE; METHYLGLYOXAL; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE C; PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; AUTOPHOSPHORYLATION; CELL CULTURE; CELL MEMBRANE; CONTROLLED STUDY; CROSS LINKING; CROSS REACTION; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME ACTIVITY; GLYCATION; HOMEOSTASIS; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0036316994     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.5.1535     Document Type: Article

References (42)

1. Nonenzymatic browning in vivo: Possible process for aging of long-lived proteins
2. Nonenzyrnatic modification of aminophospholipids by the Maillard reaction in vivo
3. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose
4. Previously unknown aldehydic lipid peroxidation compounds of arachidonic acid
5. Pharmacology of methylglyoxal: Formation, modification of proteins and nucleic acids, and enzymatic detoxification: A role in pathogenesis and antiproliferative chemotherapy
6. Lilly lecture 1993. Glycation and diabetic complications
7. Accumulation of Maillard reaction products in skin collagen in diabetes and aging
8. Role of the Maillard reaction in aging of tissue proteins: Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins
9. Cell activation by glycated proteins: AGE receptors, receptor recognition factors and functional classification of AGEs
10. Selective inhibition of mitochondrial respiration and glycolysis in human leukaemic leucocytes by methylglyoxal
11. Adaptive response of human melanoma cells to methylglyoxal injury
12. The cellular and molecular mechanisms of diabetic complications
13. Hyperglycemia, diabetes and vascular disease: An overview
14. High glucose-induced abnormal epidermal growth factor signaling
15. Epidermal growth factor binding is altered in pancreatic acini from diabetic rats
16. Decreased binding of epidermal growth factor in placentas from streptozotocin-diabetic rats
17. Decreased autophosphorylation of EGF receptor in insulin-deficient diabetic rats
18. Epidermal growth factor receptors: Critical mediators of multiple receptor pathways
19. Thyroid status modulates glycaoxidative and lipoxidative modification of tissue proteins
20. An incomplete program of cellular tyrosine phosphorylations induced by kinase-defective epidermal growth factor receptors
21. Oxidized LDLs induce massive apoptosis of cultured human endothelial cells through a calcium-dependent pathway: Prevention by aurintricarboxylic acid
22. Polyubiquitination of the epidermal growth factor receptor occurs at the plasma membrane upon ligand-induced activation
23. Activation of EGF receptor by oxidized LDL
24. Inhibition of cell proliferation by the somatostatine analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms
25. Phenolic antioxidants trolox and caffeic acid modulate the oxidized LDL-induced EGF-receptor activation
26. Glyoxal and methylglyoxal induce aggregation and inactivation of ERK in human endothelial cells
27. The reaction of some dicarbonyl sugars with aminoguanidine
28. Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction
29. Tumor necrosis factor-induced modulation of glyoxalase I activities through phosphorylation by PKA results in cell death and is accompanied by the formation of a specific methylglyoxal-derived AGE
30. The mechanism of collagen cross-linking in diabetes: A puzzle nearing resolution
31. Protein kinases 6: The eukaryotic protein kinase superfamily: Kinase (catalytic) domain structure and classification
32. Covalent modification and active site-directed inactivation of a low molecular weight phosphotyrosyl protein phosphatase
33. High glucose-induced growth factor resistance in human fibroblasts can be reversed by antioxidants and protein kinase C-inhibitors
34. Effect of methylglyoxal on human leukaemia 60 cell growth: Modification of DNAG 1 growth arrest and induction of apoptosis
35. Evidence of high levels of methylglyoxal in cultured Chinese hamster ovary cells
36. N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins
37. Alterations in nonenzymatic biochemistry in uremia: Origin and significance of "carbonyl stress" in long-term uremic complications
38. α-dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia
39. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
40. Lower-extremity amputation in diabetes: The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers
41. Advanced glycation end-products: A review
42. Protein glycation, diabetes, and aging